Almac Pharma Services Expands Its Unique Ultra-Low Temperature Solutions for Advanced Therapy Medicinal Products
March 14, 2022 12:31 ET
|
Almac Group
CRAIGAVON, Northern Ireland, March 14, 2022 (GLOBE NEWSWIRE) -- Almac Pharma Services, a member of the Almac Group providing innovative pharmaceutical development, manufacture and commercial...
POMSnet Falcon Dives Into Pharma and Biotech GMP Facilities Across the Globe
January 04, 2022 09:00 ET
|
POMS
HERNDON, Va., Jan. 04, 2022 (GLOBE NEWSWIRE) -- POMS Corporation releases POMSnet Falcon 2021.2 MES Dashboard and Analytics. POMSnet Falcon is perched to become the GMP facility standard for...
Novartis to acquire Gyroscope Therapeutics, adding a one-time gene therapy that could transform care for geographic atrophy, a leading cause of blindness
December 22, 2021 02:00 ET
|
Novartis Pharma AG
There are no currently approved therapies impacting disease progression for the up to 8 million people suffering from geographic atrophy (GA)1,2 Acquisition will add GT005 to the Novartis portfolio,...
Novartis announces T-Charge™, next-generation CAR-T platform with first-in-human data at ASH 2021
December 13, 2021 14:45 ET
|
Novartis Pharma AG
T-Charge, a next-generation platform that aims to revolutionize CAR-T cell therapy, will serve as foundation for various investigational CAR-T therapies Early data from first-in-human dose-escalation...
Novartis provides update on BELINDA study investigating Kymriah® as second-line treatment in aggressive B-cell non-Hodgkin lymphoma
August 24, 2021 01:15 ET
|
Novartis Pharma AG
Phase III BELINDA study did not meet primary endpoint of event-free survival for patients with aggressive B-cell non-Hodgkin lymphoma who had primary refractory disease or who relapsed within 12...
AGC Biologics Appoints Tony Fraij as the new General Manager/Site Head of the Longmont, Colorado Site
August 09, 2021 13:00 ET
|
AGC Biologics
LONGMONT, Aug. 09, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced a new leadership appointment...
AGC Biologics Acquires Commercial Facility, Expanding Cell & Gene Therapy Global Service Offerings
August 05, 2021 12:00 ET
|
AGC Biologics
Seattle, Aug. 05, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the finalization of the purchase of...
GMP Cytokines Market to Outstrip $158.13 Million by 2027 Growing Sturdy at 8.1% CAGR - COVID-19 Impact and Global Analysis by TheInsightPartners.com
June 11, 2021 09:38 ET
|
The Insight Partners
Pune, India., June 11, 2021 (GLOBE NEWSWIRE) -- GMP Cytokines Market: Key InsightsAccording to our new research study on “GMP Cytokines Market to 2027 – Global Analysis and Forecast – by Type,...
AGC Inc. Receives Best Acquisition Award for Adding the Former MolMed into AGC Biologics
May 19, 2021 13:10 ET
|
AGC Biologics
Seattle, May 19, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced their win of the M&A Award for...
Rentschler Biopharma establishes Center of Excellence for cell and gene therapy in the UK
February 11, 2021 04:10 ET
|
Rentschler Biopharma SE
New enterprise, Rentschler ATMP Ltd., is part of continuous innovation at Rentschler Biopharma and supports ongoing strategic international expansionCenter of Excellence to address the gap in capacity...